Holen Sie sich die Stockscreener-App
125.74
2.15%
-2.76
Handel nachbörslich:
124.40
-1.34
-1.07%
Schlusskurs vom Vortag:
$128.50
Offen:
$128.5
24-Stunden-Volumen:
1.11M
Relative Volume:
1.03
Marktkapitalisierung:
$4.25B
Einnahmen:
$401.09M
Nettoeinkommen (Verlust:
$32.64M
KGV:
133.77
EPS:
0.94
Netto-Cashflow:
$-120.51M
1W Leistung:
+19.95%
1M Leistung:
-2.67%
6M Leistung:
+68.62%
1J Leistung:
-15.30%
1-Tages-Spanne:
$122.63
$128.75
1-Wochen-Bereich:
$105.90
$131.85
52-Wochen-Spanne:
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Firmenname
Transmedics Group Inc
Sektor
Branche
Telefon
(978) 552-0900
Adresse
200 MINUTEMAN ROAD, ANDOVER, MA
Vergleichen Sie TMDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
125.74 | 4.11B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
130.69 | 221.54B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.83 | 156.19B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
380.86 | 144.43B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
89.67 | 114.47B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.24 | 46.53B | 5.69B | 4.15B | 623.10M | 6.95 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Herabstufung | Needham | Buy → Hold |
| 2024-10-29 | Bestätigt | Needham | Buy |
| 2024-10-29 | Bestätigt | Oppenheimer | Outperform |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-21 | Eingeleitet | Needham | Buy |
| 2024-06-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Eingeleitet | Stephens | Overweight |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-05-28 | Eingeleitet | Cowen | Outperform |
| 2019-05-28 | Eingeleitet | JP Morgan | Overweight |
| 2019-05-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TransMedics Group (NASDAQ:TMDX) Stock Price Up 6.8% After Analyst Upgrade - MarketBeat
5,100 Shares in TransMedics Group, Inc. (NASDAQ:TMDX) Acquired by Allianz Asset Management GmbH - MarketBeat
FDA grants conditional approval for TransMedics’ OCS ENHANCE Heart trial - Yahoo Finance
Institutional scanner results for TransMedics Group Inc.Momentum Prediction Based on AI Backtesting - Newser
How to monitor TransMedics Group Inc. with trend dashboardsBreakout Monitoring with Momentum Analysis - Newser
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $123.00 at Morgan Stanley - MarketBeat
TransMedics Group (NASDAQ:TMDX) Trading 6.8% Higher After Analyst Upgrade - Defense World
TransMedics Group, Inc. (NASDAQ:TMDX) Stock Position Lifted by HB Wealth Management LLC - MarketBeat
Why TransMedics Group Inc. is moving todayPattern Recognition Tool for ROI Investors - Newser
Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term - sharewise.com
TransMedics Stock Surge: What’s Driving the Growth? - timothysykes.com
TransMedics stock rises as FDA clears OCS heart trial (TMDX) - Seeking Alpha
Health Care Stocks See Gains On Strong Results And Approvals - Finimize
Organ Care Products Market Valuation Set to Surpass US$ 812.12 Million By 2033 | Astute Analytica - GlobeNewswire Inc.
TransMedics Group Shares Surge Amid FDA Approval - TipRanks
TransMedics stock surges after FDA grants conditional approval for heart trial - Investing.com
Can TransMedics Group Inc. hit a new high this monthFree Value Investing Picks With Stability - Newser
TransMedics Launches Largest-Ever Heart Preservation Trial Following FDA Green Light - Stock Titan
TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial04.08.25News - Ariva
TransMedics Group (NASDAQ:TMDX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
TransMedics Group (NASDAQ:TMDX) Raised to Buy at Wall Street Zen - Defense World
TransMedics Group Inc. stock trend forecast7-Day Equity Return Range Forecast Model - Newser
What analysts say about TransMedics Group Inc. stock outlookWealth Accumulation Outlook for Safe Investors - Newser
Has TransMedics Group Inc. found a price floorFundamental Forecast for Undervalued Stocks - Newser
TransMedics Group (NASDAQ:TMDX) Shares Gap Up After Strong Earnings - MarketBeat
When is the best time to buy TransMedics Group Inc. stockEntry Optimization Tool with Screener Logic - Newser
How does TransMedics Group Inc. compare to its industry peersSuperior profit margins - jammulinksnews.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
XTX Topco Ltd Makes New Investment in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Is TransMedics Group Inc. stock overvalued or undervaluedRapidly expanding wealth - jammulinksnews.com
How strong is TransMedics Group Inc. company’s balance sheetBuild a diversified portfolio for steady profits - Jammu Links News
TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Morgan Stanley Analyst Says - Defense World
What is the risk reward ratio of investing in TransMedics Group Inc. stockCapitalize on emerging market sectors - jammulinksnews.com
Is TransMedics Group Inc. a good long term investmentExceptional trading performance - Jammu Links News
What are analysts’ price targets for TransMedics Group Inc. in the next 12 monthsUnlock expert market analysis instantly - jammulinksnews.com
TransMedics Group, Inc. (TMDX): A Bull Case Theory - Insider Monkey
TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2025 Earnings Call Transcript - MSN
Should you hold or exit TransMedics Group Inc. nowDaily Technical Chart Pattern Analysis Report - Newser
Live market analysis of TransMedics Group Inc.Free Conservative Long Term Growth Plans - Newser
Using AI based signals to follow TransMedics Group Inc.Free Entry and Exit Strategy Optimizer Tool - Newser
How high can TransMedics Group Inc. stock price go in 2025Sector Rotation Strategy for Smart Traders - Newser
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
TransMedics outlines 35% 2025 revenue growth outlook as global expansion and clinical programs accelerate - MSN
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up - TradingView
Envestnet Asset Management Inc. Cuts Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
What TransMedics Just Taught Me About Trusting The Algorithm - Benzinga
Here's Why TransMedics Group (NASDAQ:TMDX) Has Caught The Eye Of Investors - Yahoo Finance
TransMedics: Continued Strength Suggests Further Upside - Seeking Alpha
TransMedics Group (NASDAQ:TMDX) Shares Gap Up Following Earnings Beat - Defense World
TransMedics Reports Strong Q2 2025 Financial Results - The Globe and Mail
Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):